Oxacyclohexadeca-3,11,13-triene-2,10-dione,15-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-6-[[(4S,5R,6R,7S,9R)-6-hydroxy-4,9-dimethyl-2-oxo-1,3,8-trioxaspiro[4.5]dec-7-yl]oxy]-5,7,9,16-tetramethyl-,(3E,5S,6S,7S,9R,11E,13E,15R,16R)-,112008-27-2 Products Supply

Name: Oxacyclohexadeca-3,11,13-triene-2,10-dione,15-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-6-[[(4S,5R,6R,7S,9R)-6-hydroxy-4,9-dimethyl-2-oxo-1,3,8-trioxaspiro[4.5]dec-7-yl]oxy]-5,7,9,16-tetramethyl-,(3E,5S,6S,7S,9R,11E,13E,15R,16R)-
CAS NO.: 112008-27-2
Synonyms:
AldgamycinF, 12,13-deepoxy-12,13-didehydro-8-deoxy-, (7Ax,12E)-; 1,3,8-Trioxaspiro[4.5]decane, aldgamycin Fderiv.; Oxacyclohexadecane, aldgamycin F deriv.; Swalpamycin
Molecular Structure:
Molecular Formula: C37H56 O14

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; 4,17-Dioxabicyclo[14.1.0]hepta; 4,17-Dioxabicyclo[14.1.0]hepta; Oxacyclohexadeca-3,11,13-trien; (3E,5S,6S,7S,9R,11E,13E,15R,16; Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; Oxacyclohexadeca-3,11,13-trien; L-Ribonamide,N-[(3S)-3-[4-[(1E; [(2S,3R,4R,6S)-6-[(2R,3S,4R,5R; 6-Nonenoic acid,2,4,6-trimethy; (4R,5S,6S,7R,9R,11E,13E,15R,16; (4R,5S,6S,7R,9R,11E,13E,15S,16; L-Ribonamide,N-[(1R,3S)-3-[4-[; L-Ribonamide,N-[(3S)-3-[4-[(1E; L-Ribonamide,N-[(1R,3S)-3-[4-[; L-Ribonamide,N-[(3S)-3-[4-[(1E; (4S,5S,6S,7R,9R,10R,11E,13E,16; Oxacyclohexadeca-3,5,11,13-tet; (4S,5S,6S,7R,9R,10R,11E,13E,16; 4-amino-N-(4,6-dimethylpyrimid; 4-[(3-carboxy-2-hydroxy-naphth; Oxacyclohexadeca-3,5,11,13-tet; (4S,5S,6S,7R,9R,10R,11E,13E,16; 19-Oxa-1,4,7,25-tetraazabicycl; 6-Nonenoic acid,2,4,6-trimethy;